COST-EFFECTIVENESS OF ICOSAPENT ETHYL IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME IN CATALONIA

被引：0
|
作者：
Mistry, C. [1 ]
Tilley, L. [2 ]
Comin-Colet, J. [2 ]
Vitale, G. [3 ]
Gaugris, S. [1 ]
Jakouloff, D. [4 ]
机构：
[1] FIECON Ltd, St Albans, England
[2] Hosp Univ Bellvitge, Barcelona, Spain
[3] Amarin Spain & Portugal, Madrid, Spain
[4] Amarin Switzerland GmbH, Zug, Switzerland
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE611
引用
收藏
页码：S175 / S176
页数：2
相关论文
共 50 条
  • [21] Consistent Cost-effectiveness of Icosapent Ethyl Across Patient Profiles From REDUCE-IT
    Zhang, Zugui
    Bhatt, Deepak L.
    Dolman, Sarahfaye
    Boden, William E.
    Steg, Philippe G.
    Miller, Michael
    Brinton, Eliot A.
    King, Jordan B.
    Bress, Adam P.
    Jacobson, Terry A.
    Tardif, Jean-Claude
    Ballantyne, Christie M.
    Kolm, Paul
    Weintraub, William S.
    CIRCULATION, 2020, 142
  • [22] LONG-TERM COST-EFFECTIVENESS OF TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THAILAND
    Permsuwan, U.
    Yamwong, S.
    Tinmanee, S.
    Sritara, P.
    VALUE IN HEALTH, 2012, 15 (07) : A633 - A633
  • [23] COST-EFFECTIVENESS ANALYSIS OF TICAGRELOR IN TREATING PATIENTS WITH ACUTE CORONARY SYNDROME IN HONG KONG
    Wu, D. B. C.
    Lee, B. S. C.
    Lee, K. K. C.
    VALUE IN HEALTH, 2014, 17 (07) : A487 - A487
  • [24] A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN PATIENTS WITH NON STABLE ACUTE CORONARY SYNDROME IN GREECE
    Kourlaba, G.
    Fragoulakis, V
    Maniadakis, N.
    VALUE IN HEALTH, 2011, 14 (07) : A377 - A378
  • [25] Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome
    Laura Pirhonen
    Hanna Gyllensten
    Andreas Fors
    Kristian Bolin
    The European Journal of Health Economics, 2020, 21 : 1317 - 1327
  • [26] Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome
    Pirhonen, Laura
    Gyllensten, Hanna
    Fors, Andreas
    Bolin, Kristian
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (09): : 1317 - 1327
  • [27] Cost-effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome
    Lee, Peter
    Liew, Danny
    Brennan, Angela
    Stub, Dion
    Lefkovits, Jeffrey
    Reid, Christopher M.
    Zomer, Ella
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 156 : 44 - 51
  • [28] Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Dong, Olivia M.
    Wheeler, Stephanie B.
    Cruden, Gracelyn
    Lee, Craig R.
    Voora, Deepak
    Dusetzina, Stacie B.
    Wiltshire, Tim
    VALUE IN HEALTH, 2020, 23 (01) : 61 - 73
  • [29] Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis
    Lala, A.
    Berger, J. S.
    Sharma, G.
    Hochman, J. S.
    Braithwaite, R. Scott
    Ladapo, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 81 - 91
  • [30] Cost-effectiveness of prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention
    Spartalis, Michael
    Tzatzaki, Eleni
    Nikiteas, Nikolaos I.
    Spartalis, Eleftherios
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 251 : 32 - 32
12345